This site is intended for health professionals only

Editor’s pick

A vision of the future
A vision of the future
Vivitrol approved to treat addicts
Vivitrol approved to treat addicts
Jazz drug needs more tests – FDA
Jazz drug needs more tests – FDA
Revolutionary prostate drug tested
Revolutionary prostate drug tested
Avastin boost for ovarian cancer
Avastin boost for ovarian cancer
Fight for a world free of leprosy
Fight for a world free of leprosy
UCB and Synosia Therapeutics sign strategic alliance in neurology
UCB and Synosia Therapeutics sign strategic alliance in neurology
Iressa as first line treatment for NSCLC patients?
Iressa as first line treatment for NSCLC patients?
New hope for lung cancer patients
New hope for lung cancer patients
Shire appoints new R & D senior vice president
Shire appoints new R & D senior vice president
Erbitux offers hope to head and neck cancer patients
Erbitux offers hope to head and neck cancer patients
Combination treatment could be key to treating patients with advanced NET
Combination treatment could be key to treating patients with advanced NET
1 … 36 37 38 39 40 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x